MARYSVILLE, Mich. (AP) - Authorities say multiple explosions have been reported and at least one person has been hospitalized after a fire broke out at a Michigan welding supply company.
BETSY VERECKEY AP Business Writer - November 2, 2009 CHICAGO (AP) - The Clorox Co. said Monday profit rose 23 percent in its fiscal first quarter, as consumers paid higher prices and stocked up on disinfecting products because of worries about the flu.
SILVER SPRING, Md. (AP) - The U.S. Food and Drug Administration sent a warning letter Friday to Procter & Gamble Co. saying the company was illegally marketing two Vicks cold and flu medicines containing vitamin C.
BOSTON (AP) - Massachusetts lawmakers are considering tighter restrictions on the use of toxic chemicals in consumer products as a way to encourage the use of safer alternatives.
By Tom Zsolt, PE, Vice President, Platform Computing When they first came to market, high
FRANK BAJAK & JEANNETH VALDIVIESO Associated Press Writers - October 30, 3009
CHRIS KAHN AP Energy Writer - October 30, 3009 NEW YORK (AP) - Chevron said Friday it pushed its way through a weak third quarter by pumping more oil out of the ground as prices recovered from a severe plunge earlier in the year.
Jim Lane Biofuels Digest - October 30, 3009 Generally recognized â€œhot
SAM HANANEL Associated Press Writer - October 30, 3009 WASHINGTON (AP) - The
BANGKOK (PRNewswire) - Bayer HealthCare presented results from a global Phase II study of florbetaben, its imaging agent in development for the detection of cerebral beta-Amyloid plaques, at the 19th World Congress of Neurology (WCN).
BASEL, Switzerland (AP) - Swiss specialty chemicals and biotech company Lonza Group AG said Thursday it is cutting 450 jobs, or about 5 percent of its global workforce.
A Philly cheesesteak sandwich is a culinary indulgence to some and a dietary staple to others.
MARY ESCH Associated Press Writer - October 29, 2009 LOCH SHELDRAKE, N.Y. (AP) -
JEANNETH VALDIVIESO Associated Press Writer - October 29, 2009 QUITO, Ecuador (AP) - Foreign pharmaceutical companies accepted on Wednesday Ecuador's decision to bypass patents in order to produce less expensive generic versions of some patented drugs.